Reprint notice: This is a short digest based on public FDA information. Copyright remains with the original publisher.
On August 19, 2026, the FDA authorized Aletta, the first standalone robotic device designed to draw blood from an adult patient without hands-on operator intervention. It uses near-infrared light and Doppler ultrasound to locate a suitable vein and operates under trained supervision.
Source：U.S. Food and Drug Administration · View original ↗